Holliston

Holliston biotech Biostage ended 2017 with about $4 million in cash on hand, and that will carry the company only partially through this year's third quarter.

The Massachusetts Biotechnology Council, a nonprofit formed three decades ago to support the state's life sciences industry, is aiming to make it easier for communities to make themselves ready through the right zoning and permitting programs.

Holliston medical device maker Biostage has added another children's hospital executive as the company continues to remake itself into a child-focused biotech company.

Funding for Biostage's bioengineered throat organ implants continues to pile up, as the Holliston company announced Thursday it has been awarded a grant worth up to $1.7 million.

Holliston retailer of ice hockey equipment Pure Hockey will be the retail partner of the National Hockey League and its Players' Association's program for young players.

Holliston biotech Biostage is eyeing formal clinical trials after results of a large animal study show the company's artificial throat implants can regenerate a functioning esophagus.

Another powerful nor'easter, this one on the heels of a storm that battered the East Coast last week, has caused power outages to more than 368,000 Massachusetts homes and businesses on Thursday.

Holliston life sciences firm Harvard Biosciences reported a $900,000 loss in 2017, as revenues declined by $2.6 million for the year.

Biostage, a Holliston-based biotech specializing in regenerative medicine to treat diseases of the throat, announced on Tuesday its first esophageal implant resulted in a regenerated esophageal tube.

Holliston biotech Biostage has appointed another medical professional to its scientific advisory board as the company continues its makeover following a near bankruptcy position just months ago.